Trualt Bioenergy Ltd (TRUALT) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Trualt Bioenergy Ltd on NSE and BSE, with an AI summary of each filing.
Monitoring Agency Report for the quarter ended on September 30, 2026.
Others (Uncategorized) · 31 Oct 2026, 12:56 am
TruAlt Bioenergy Q2 FY27 IPO Proceeds Utilization Report Shows Minimal Deviations Crisil Ratings reported that TruAlt Bioenergy utilized Rs 741.22 crore of its Rs 750.00 crore gross IPO proceeds as of 30th Sep'26, leaving Rs 8.78 crore unutilized. Net issue proceeds of Rs 657.04 crore saw Rs 656.73 crore deployed, including Rs 425.00 crore for working capital and Rs 81.36 crore for general corporate purposes, both fully utilized by 31st Mar'26. Multi-feedstock capex reached Rs 150.37 crore against Rs 150.68 crore budgeted, with remaining unutilized funds held across monitoring and public offer bank accounts.
Earnings Call Transcript
Transcript · 29 Oct 2026, 5:57 pm
Intimation of recording of earnings call held on 26 October 2026
Audio / Video · 26 Oct 2026, 11:04 pm
TruAlt Bioenergy Releases Audio Recording of Q2/H1 FY27 Earnings Call TruAlt Bioenergy Limited has made available the audio recording of its earnings conference call held on 26th Oct'26 at 11:30 AM IST. The call discussed the company's unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The recording has been uploaded to the company's website pursuant to Regulation 30 and Regulation 46 of SEBI LODR Regulations.
Results-Financial Results for September 30,2026.
Financial Result · 24 Oct 2026, 10:28 pm
Press Release under Regulation 30 of SEBI (LODR) Regulations 2015
Press Release · 24 Oct 2026, 2:42 am
TruAlt Bioenergy Reports Strong H1 FY27 Results Driven by Dual-Feed Ethanol Expansion TruAlt Bioenergy reported robust H1 FY27 consolidated revenue of ₹1,437.98 crore, up 243% YoY, while EBITDA jumped 532% YoY to ₹233.92 crore with margins expanding 744 bps to 16.27%. PAT turned positive at ₹94.27 crore versus a ₹33.27 crore loss in H1 FY26. For Q2 FY27, revenue reached ₹811.10 crore with PAT of ₹34.99 crore. Growth was driven by 1,300 KLPD dual-feed integration across 65% of its 2,000 KLPD capacity. Strategic pipeline includes CBG partnerships with Sumitomo and GAIL, plus a ₹150-crore grant-backed SAF project.
Investor Presentation
Investor Presentation · 24 Oct 2026, 2:39 am
TruAlt Bioenergy Q2 & H1 FY27 Financial and Operational Performance TruAlt Bioenergy reported strong consolidated growth for H1 FY27, with total income surging 221% YoY to ₹1,465.14 Cr and EBITDA jumping 532% YoY to ₹233.92 Cr (margin at 16.27%). PAT swung to ₹94.27 Cr from a loss of ₹33.27 Cr in H1 FY26. For Q2 FY27, total income reached ₹823.74 Cr, EBITDA stood at ₹101.16 Cr, and PAT reached ₹34.99 Cr. Growth was led by ethanol operations, which contributed ₹1,262.64 Cr in revenue, supported by 2,000 KLPD capacity with 1,300 KLPD dual-feed integration.
Outcome of Board Meeting for approval of Unaudited Financial Results(Standalone and Consolidated) along with Limited Review Report thereon, for the Quarter and Half Year ended on September 30, 2026.
Outcome · 24 Oct 2026, 1:33 am
TruAlt Bioenergy Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 24 Oct 2026, 1:18 am
Trualt Bioenergy Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 81,110 (+606.2% YoY | +29.4% QoQ) ■ EBITDA: 10,116 (Loss to Profit YoY | -23.8% QoQ) ■ EBITDA Margin (%): 12.5 (Loss to Profit YoY | -871 bps QoQ) ■ PAT: 3,468 (Loss to Profit YoY | -39.3% QoQ) ■ EPS (INR): 4.04 (Loss to Profit YoY | -39.4% QoQ)
Resignation of Mr. Monu Kumar From the post of Company Secretary and Compliance Office of the Company w.e.f 16.10.2026.
Change in Management · 17 Oct 2026, 8:57 pm
TruAlt Bioenergy Announces Resignation of Company Secretary Monu Kumar TruAlt Bioenergy Limited announced that Monu Kumar has resigned from his position as Company Secretary, Compliance Officer, and Key Managerial Personnel due to personal reasons, with no other material reasons reported. The company accepted his resignation and relieved him from his duties effective from the close of business hours on 16th Oct'26. The resignation will be placed before the Board of Directors at the upcoming board meeting for formal noting.
TruAlt Bioenergy Limited has informed the Exchange about Schedule of meet
Intimation · 26 Oct 2026, 11:30 am
TruAlt Bioenergy Schedules Q2 FY27 Earnings Call for Oct'26 TruAlt Bioenergy Limited will host its Q2 and H1 FY27 earnings conference call on 26th Oct'26 at 11:30 AM IST to discuss unaudited financial results for the period ended 30th Sep'26. As India's largest ethanol producer by installed capacity, the company operates across ethanol and compressed biogas, with ongoing expansions into 2G ethanol, sustainable aviation fuel, and biochemicals aligned with the National Biofuels Policy and Ethanol Blending Program. Call recordings and transcripts will be published on the company's website following the event.
TruAlt Bioenergy Limited has informed the Exchange about Board Meeting to be held on 23-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 23 Oct 2026, 5:30 am
TruAlt Bioenergy Limited has informed the Exchange about Board Meeting to be held on October 23, 2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarter and half year ended September 2026
Intimation · 23 Oct 2026, 5:30 am
Trualt Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve TruAlt Bioenergy Limited has ....
Intimation · 23 Oct 2026, 5:30 am
TruAlt Bioenergy Board to Consider Q2 and H1 FY27 Results on 23rd Oct'26 TruAlt Bioenergy Limited announced that its Board of Directors will meet on 23rd Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in the company's securities remains closed for all designated persons and their immediate relatives until 48 hours post the submission of the results to the stock exchanges.
TruAlt Bioenergy Limited has informed the Exchange regarding purchase of additional shares by Nirani Holdings Private Limited in the Company
Others (Uncategorized) · 01 Oct 2026, 12:15 am
TruAlt Bioenergy Promoter Group Entity Acquires Additional 0.23% Stake Nirani Holdings Private Limited, part of the promoter group of TruAlt Bioenergy Limited, acquired 1,96,129 equity shares via open market purchases on NSE and BSE on 30th Sep'26. The transaction was executed at an average price of Rs. 463.61 per share, totaling Rs. 9.09 crore. Following this acquisition, Nirani Holdings' equity stake in TruAlt Bioenergy increased from 2.25% (19,31,644 shares) to 2.48% (21,27,773 shares).
TruAlt Bioenergy Limited has informed the exchange regarding creation of Pledge of shares by Mrs. Kamala Murugesh Nirani
Others (Uncategorized) · 29 Sept 2026, 12:56 am
TruAlt Bioenergy Promoter Group Member Kamala Murugesh Nirani Pledges Shares TruAlt Bioenergy Limited promoter group member Kamala Murugesh Nirani pledged 3,00,000 equity shares (0.35% of total share capital, valued at ₹13.17 Cr) on 25th Sep'26 with Jio Credit Limited. The encumbrance secures debt availed by promoters Mr. Vijaykumar Nirani and Mr. Vishal Nirani to finance the acquisition of company shares and increase their shareholding. Post-transaction, her total encumbered shares increased to 42,27,590 equity shares, representing 100% of her 4.93% total equity holding in the company.
TruAlt Bioenergy Limited has informed the Exchange regarding purchase of additional shares by Nirani Holdings Private Limited in the Company
Others (Uncategorized) · 28 Sept 2026, 10:00 pm
TruAlt Bioenergy Promoter Group Entity Acquires Additional Stake via Open Market Promoter group entity Nirani Holdings Private Limited acquired 1,22,032 equity shares of TruAlt Bioenergy Limited on 28th Sep'26 via open-market purchases on the NSE at an average price of Rs. 458.05 per share, aggregating to Rs. 5.57 Cr. Following this transaction, Nirani Holdings' stake in TruAlt Bioenergy increased from 2.11% (18,09,612 shares) to 2.25% (19,31,644 shares).
TruAlt Bioenergy Limited has informed the exchange regarding Purchase of additional shares by Nirani Holdings Private Limited in the Company.
Others (Uncategorized) · 25 Sept 2026, 9:35 pm
Promoter Group Entity Nirani Holdings Increases Stake in TruAlt Bioenergy Nirani Holdings Private Limited, a promoter group entity of TruAlt Bioenergy Limited, acquired 1,52,201 equity shares via open-market transactions on the NSE on 25th Sep'26. The acquisition was executed at an average price of Rs 439.32 per share, representing a total consideration of Rs 6.69 cr. Consequently, Nirani Holdings' stake in TruAlt Bioenergy increased from 1.93% (16,57,411 shares) to 2.11% (18,09,612 shares).
TruAlt Bioenergy Limited has informed the exchange regarding creation of pledge of shares by Nirani Holdings Private Limited
Others (Uncategorized) · 24 Sept 2026, 10:00 pm
TruAlt Bioenergy Promoter Group Pledges 1.63% Stake to Fund Share Acquisition Promoter group entity Nirani Holdings Private Limited created a pledge on 14,00,000 equity shares (1.63% of total share capital, valued at ₹58.10 Cr) of TruAlt Bioenergy Limited on 22nd Sep'26 in favour of Jio Credit Limited. The encumbrance secures debt availed by promoters Vijaykumar Nirani and Vishal Nirani to finance the acquisition of additional company shares and raise their overall holding. Post-transaction, Nirani Holdings maintains a total equity holding of 16,57,411 shares (1.93%).
Please Find attached the Intimation
Others (Uncategorized) · 23 Sept 2026, 5:03 pm
TruAlt Bioenergy Restores LODR Compliance Following Exchange Fines TruAlt Bioenergy paid stock exchange fines levied for regulatory non-compliances under SEBI LODR Regulations 17(1) and 29. Penalties included Rs. 536,900 (inclusive of 18% GST) for a 91-day delay in appointing a Woman Independent Director for the quarter ended 30th Jun'26, and Rs. 11,800 for delayed prior board meeting intimation for Jul'26. The company restored board composition compliance on 22nd Sep'26 by appointing Dr. Sarvamangala R. Patil as Non-Executive Independent Woman Director, clarifying the procedural lapses were unintentional.
TruAlt Bioenergy Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'.
Intimation · 23 Sept 2026, 4:59 pm
TruAlt Bioenergy Limited has informed the Exchange regarding Outcome of Board Meeting held on September 22, 2026.
Outcome · 22 Sept 2026, 10:54 pm
TruAlt Bioenergy Approves Rs 29.69 Crore Investments in Bioenergy Subsidiaries TruAlt Bioenergy’s board approved additional cash equity investments totaling Rs 29.69 cr in two 51%-owned compressed biogas subsidiaries on 22nd Sep'26. The company will invest Rs 21.42 cr at par in Leafiniti Bioenergy (JV with GAIL India) by 10th Oct'26, and Rs 8.27 cr at Rs 34 per share (including Rs 24 premium) in TruAlt Sumi Gas (JV with Sumitomo Corporation) by 27th Sep'26 to support expansion. Additionally, Dr. Sarvamangala R Patil was appointed as Non-Executive Independent Director for one year, subject to shareholder approval.
Please find attached the outcome of the Board meeting held on September 22, 2026
Others (Uncategorized) · 22 Sept 2026, 10:49 pm
TruAlt Bioenergy Approves ₹29.69 Cr Subsidiary Investments and Board Appointment On 22nd Sep'26, TruAlt Bioenergy's board approved an additional investment of ₹21.42 Cr in its 51% subsidiary Leafiniti Bioenergy via 2.142 Cr equity shares at par (₹10 each), targeted for completion by 10th Oct'26. The board also cleared an additional investment of ₹8.27 Cr in 51% subsidiary TruAlt Sumi Gas via 24.32 lakh shares at ₹34 per share (including ₹24 premium), closing by 27th Sep'26. Additionally, Dr. Sarvamangala R Patil was appointed as Non-Executive Independent Director for one year, subject to shareholder approval via postal ballot.
Disclosure under Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading), Regulation 2015
Others (Uncategorized) · 17 Sept 2026, 11:06 pm
Promoter Group Entity Nirani Holdings Increases Stake in TruAlt Bioenergy Nirani Holdings Private Limited, a promoter group entity of TruAlt Bioenergy Limited, acquired 50,000 equity shares via open market purchase on NSE on 17th Sep'26. The transaction was executed at an average price of Rs. 424.64 per share, totaling Rs. 2.12 cr. Following this acquisition, Nirani Holdings' stake in TruAlt Bioenergy increased from 1.87% (16,07,411 shares) to 1.93% (16,57,411 shares).
Disclosure under Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading), Regulation 2015
Others (Uncategorized) · 17 Sept 2026, 4:11 am
TruAlt Bioenergy Promoter Group Entity Acquires 0.08% Stake via Open Market Promoter group entity Nirani Holdings Private Limited acquired 69,575 equity shares of TruAlt Bioenergy Limited via an open-market transaction on the NSE on 16th Sep'26. The purchase was executed at an average price of Rs 422.27 per share, aggregating to an investment of Rs 2.94 crore. Following the acquisition, Nirani Holdings' stake in TruAlt Bioenergy increased from 1.79% (15,37,836 shares) to 1.87% (16,07,411 shares).
Disclosure under Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading), Regulation 2015
Others (Uncategorized) · 16 Sept 2026, 12:49 am
TruAlt Bioenergy Promoter Group Entity Nirani Holdings Increases Stake to 1.79% Promoter group entity Nirani Holdings Private Limited acquired 98,700 equity shares of TruAlt Bioenergy Limited via open market purchases on the NSE on 15th Sep'26. The transaction was executed at an average price of Rs. 410.85 per share, aggregating to a total consideration of Rs. 4.06 crore. Following this acquisition, Nirani Holdings' stake in TruAlt Bioenergy increased from 1.68% (14,39,136 shares) to 1.79% (15,37,836 shares).